PKNOX2 divergent transcript (PKNOX2-DT)

PKNOX2 divergent transcript (PKNOX2-DT), also called PKNOX2-AS1 or PKNOX2 antisense RNA 1 (head to head), is a long non-coding RNA (lncRNA) transcribed from the region adjacent or opposite to the PKNOX2 coding gene. It is annotated in genomic and gene databases, but there are no peer-reviewed experimental studies to date that clarify its molecular function, biological processes, or any disease link. Its nomenclature (including "AS1" for antisense RNA 1) indicates it is an antisense transcript, potentially involved in gene regulation, especially related to the adjacent PKNOX2 gene. However, unlike PKNOX2, which is a well-studied protein-coding transcription factor, PKNOX2-DT is currently an uncharacterized lncRNA without evidence of being a direct therapeutic target or having direct clinical relevance[5]. Key considerations: - PKNOX2-DT is not a conventional therapeutic target such as a receptor, transporter, enzyme, or transcription factor. - It should not be confused with the protein-coding PKNOX2 gene, which encodes a transcription factor involved in development and disease[1][2][3][4]. - PKNOX2-DT is a distinct non-coding entity with no known drug interactions, mechanisms of pharmacological action, or established biomarker status.

Other names

PKNOX2-AS1PKNOX2 antisense RNA 1 (head to head)PKNOX2-DT

Not applicable; no drugs or direct interventions reported